Related Experiment Videos

Loss of vessel wall viability in cerebral amyloid angiopathy

R Prior1, D D'Urso, R Frank

  • 1Department of Neurology, University of Düsseldorf, Germany.

Neuroreport
|January 31, 1996
PubMed

Insights

Cerebral amyloid angiopathy (CAA) involves amyloid beta protein deposits in brain vessels. This study found these deposits cause vessel wall cell death and dilation, increasing cerebral hemorrhage risk in elderly individuals.

Area of Science:

  • Neuropathology
  • Vascular Biology
  • Gerontology

Background:

  • Cerebral amyloid angiopathy (CAA) is a key feature of Alzheimer's disease.
  • CAA contributes significantly to cerebral hemorrhage in the elderly.
  • It involves amyloid beta (A beta) protein deposition in cerebral and leptomeningeal vessels.

Purpose of the Study:

  • To investigate the in vivo effects of cerebrovascular A beta deposits.
  • To analyze the viability of leptomeningeal vessels in dogs with CAA.

Main Methods:

  • Analysis of living canine leptomeninges from old dogs with CAA.
  • Confocal laser scanning microscopy.
  • Immunofluorescence staining for A beta and fluorescein diacetate (FDA) viability staining.

Main Results:

  • Segmental loss of leptomeningeal vessel wall viability was observed at sites of A beta deposition.
  • Non-viable vessel segments were frequently dilated.
  • A beta deposition correlates with reduced vascular viability.

Conclusions:

  • A beta-induced vascular cell death is implicated in CAA.
  • Vascular dilation in affected areas may create "loci minores resistentiae" (areas of reduced resistance).
  • This mechanism likely contributes to cerebral hemorrhage development in CAA.

Related Concept Videos